Literature DB >> 16985727

Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas.

A Pantuck, A Zisman, A Belldegrun.   

Abstract

Entities:  

Year:  2000        PMID： 16985727      PMCID： PMC1476093     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  4 in total

1.  Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a.

Authors:  W J Berg; D M Nanus; A Leung; K T Brown; B Hutchinson; M Mazumdar; X C Xu; R Lotan; V E Reuter; R J Motzer
Journal:  Clin Cancer Res       Date:  1999-07       Impact factor: 12.531

2.  Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

Authors:  R J Motzer; M Mazumdar; J Bacik; W Berg; A Amsterdam; J Ferrara
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

3.  Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.

Authors:  P M Dodd; J A McCaffrey; H Herr; M Mazumdar; J Bacik; G Higgins; M G Boyle; H I Scher; D F Bajorin
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

4.  Prognostic factors in metastatic renal carcinoma.

Authors:  J D Maldazys; J B deKernion
Journal:  J Urol       Date:  1986-08       Impact factor: 7.450
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.